Argenx is a biopharmaceutical company that develops antibody-based medicines for people with severe autoimmune diseases. Its main product is an antibody therapy designed to reduce harmful autoantibodies, and it is used to treat conditions such as myasthenia gravis and other immune disorders. The company carries out research, clinical development and commercial activities, serving patients and healthcare providers in several countries. Argenx is based in the Netherlands, with additional operations in Belgium and the United States.
The shares are listed on the London Stock Exchange in UK under the code 0QW0, and the price on this page is in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #1012 of 3788 on the London Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendFair
68/100
Mixed trend against its averages.
See the numbers →
Above 200-day average5.1%
From 52-week high-14.7%
MomentumFair
64/100
Typical recent returns for this exchange.
See the numbers →
3-month return-2.4%
6-month return15.3%
12-month, skipping last month19.8%
Stability (higher is calmer)Weak
50/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)37.7%
Worst drawdown, 1 year (smaller is calmer)-27.4%
LiquidityStrong
80/100
Trades actively.
See the numbers →
Avg daily value traded22.54M EUR
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 569.00 – 924.70Daily closes, split-adjusted
Signals
50-day average833.59
200-day average740.36
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)28.64
Technical summary
Daily
Neutral
6 bullish · 2 neutral · 8 bearish
Weekly
Bullish
7 bullish · 1 neutral · 4 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
765.2
Bullish
EMA 10
773.3
Bullish
SMA 20
776.6
Bullish
EMA 20
782.1
Bearish
SMA 50
833.6
Bearish
EMA 50
800.3
Bearish
SMA 100
803.6
Bearish
EMA 100
790.0
Bearish
SMA 200
740.4
Bullish
EMA 200
754.4
Bullish
Oscillators (daily)
RSI (14)
47.25
Neutral
MACD (12, 26)
-14.69
Bearish
Momentum (12)
7.80
Bullish
Stochastic %K (14)
84.79
Bearish
Williams %R (14)
-15.21
Bearish
CCI (20)
5.66
Neutral
Pivot points (classic, last session)
S3
774.0
S2
776.0
S1
777.1
Pivot
779.1
R1
780.2
R2
782.2
R3
783.3
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in EUR. Educational only, not financial advice.
